Extranuclear steroid receptors: Nature and actions

Endocrine Reviews

Volumn 28, Issue 7, 2007, Pages 726-741

  Hammes, Stephen R ^a,d   Levin, Ellis R ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CALCIUM; CYCLIC AMP; CYCLIC GMP; ESTROGEN; ESTROGEN RECEPTOR; MINERALOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE DERIVATIVE; PROTEIN KINASE C; STEROID RECEPTOR; THYROID HORMONE; VITAMIN D RECEPTOR;

AMINATION; ANIMAL CELL; CALCIUM SIGNALING; CARDIOVASCULAR RESPONSE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MEMBRANE INITIATED STEROID SIGNALING; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION;

EID: 37349081370     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2007-0022     Document Type: Review

References (211)

1. Selye H 1950 Stress and the general adaptation syndrome. Brit J Med 1:1383-1392
2. Szego CM, Davis JS 1967 Adenosine 3′, 5′-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 58:1711-1718
3. Pietras RJ, Szego CM 1975 Endometrial cell calcium and oestrogen action. Nature 253:357-359
4. Pietras RJ, Szego CM 1977 Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265:69-72
5. Losel R, Wehling M 2003 Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 4:46-56
6. Levin ER 2005 Integration of the extra-nuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959
7. Hisamoto K, Bender JR 2005 Vascular cell signaling by membrane estrogen receptors. Steroids 70:382-387
8. 13 to drive actin remodeling and endothelial cell migration via the rhoA/rho kinase/moesin pathway. Mol Endocrinol 20:1756-1771
9. Razandi M, Alton G, Pedram A, Ghonshani S, Webb D, Levin, ER 2003 Identification of a structural determinant for the membrane localization of ER α. Mol Cell Biol 23:1633-1646
10. Pappas TC, Gametchu B, Yannariello-Brown J, Collins TJ, Watson CS 1995 Membrane estrogen receptors identified by multiple antibody labeling and impeded ligand binding. FASEB J 9:404-410
11. Norfleet AM, Thomas ML, Gametchu B, Watson CS 1999 Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140:3805-3814
12. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors derive from a single transcript: studies of ERα and ERβ expressed in CHO cells. Mol Endocrinol 13:307-319
13. Marquez D, Chen H-W, Curran E, Welshons WV, Pietras RJ 2006 Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 246:91-100
14. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER 2004 Plasma membrane estrogen receptors exist and function as dimers. Mol Endocrinol 18:2854-2865
15. Pedram A, Razandi M, Levin ER 2006 Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996-2006
16. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW 2002 ERβ has nongenomic action in caveolae. Mol Endocrinol 16:938-946
17. Stabile L, Davis A, Gubish C, Hopkins T, Luketich JD, Christie N, Finkelstein S, Siegfried JM 2002 Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res 62:2141-2150
18. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR 2000 Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Nat Acad Sci USA 97:5930-5935
19. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, Bayard F, Arnal JF 2002 The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 99:2205-2210
20. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW 2001 Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gα (i). J Biol Chem 276:27071-27076
21. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF 2006 A variant of estrogen receptor-α, hER-α36: transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103:9063-9068
22. Pedram A, Razandi R, Aitkenhead M, Levin ER 2005 Estrogen inhibits cardiomyocyte hypertrophy in vitro: antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 280:26339-26348
23. Filardo EJ, Quinn JA, Bland KI, Frackelton AR 2000 Estrogeninduced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, gpr30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660
24. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630
25. Thomas P, Pang Y, Filardo EJ, Dong J 2004 Identity of an estrogen membrane receptor coupled to a G-protein in human breast cancer cells. Endocrinology 164:624-632
26. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S, Maggiolini M 2005 The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17-β estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20:631-646
27. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Ando S, Maggiolini M 2007 G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866
28. Kanda N, Watanabe S 2004 17β-Estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J Invest Dermatol 123:319-328
29. Spiegel S, Milstien S 2007 Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 282:2125-2129
30. Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA, Xia P 2006 Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 173:301-310
31. Levin ER 2003 Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17:309-317
32. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
33. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ 2004 The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc Natl Acad Sci USA 101:2076-2081
34. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH 2004 Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proc Natl Acad Sci USA 101:17126-17131
35. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ 2003 Rapid signaling of estrogen in hypothalamic neurons involves a novel G protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23:9529-9540
36. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly Jr ES, Nethrapalli IS, Tinnikov AA 2002 ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 19:8391-8401
37. Moro L, Reineri S, Piranda D, Pietrapiana D, Lova P, Bertoni A, Graziani A, Defilippi P, Canobbio I, Torti M, Sinigaglia F 2005 Nongenomic effects of 17β-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor β and Src kinase. Blood 105:115-121
38. Reineri S, Bertoni A, Sanna E, Baldassarri S, Sarasso C, Zanfa M, Canobbio I, Torti M, Sinigaglia F 2007 Membrane lipid rafts coordinate estrogen-dependent signaling in human platelets. Biochim Biophys Acta 1773:273-278
39. Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Chaudry IH 2007 Salutary effects of 17β-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor α. Am J Physiol Cell Physiol 292:C2103-C2111
40. Hirano S, Furutama D, Hanafusa T 2007 Physiologically high concentrations of 17β-estradiol enhance NF-βB activity in human T cells. Am J Physiol Regul Integr Comp Physiol 292:R1465-R1471
41. Tamrazi A, Carlson KE, Daniels JR, Hurth KM, Katzenellenbogen JA 2002 Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. Mol Endocrinol 16:2706-2719
42. Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW 2005 Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERα domains with known nuclear functions. Mol Endocrinol 19:277-289
43. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I 1999 Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem Biophys Res Commun 263:257-262
44. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER 2002 Estrogen receptors associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115
45. Razandi M, Pedram A, Parks S, Levin ER 2003 Proximal events in ER signaling from the plasma membrane. J Biol Chem 278:2701-2712
46. Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M 2004 SPalmitoylation modulates human estrogen receptor-α functions. Biochem Biophys Res Commun 316:878-883
47. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M 2004 Palmitoylatin-dependent estrogen receptor (α) membrane localization regulation by 17β-estradiol. Mol Biol Cell 16:231-237
48. Li L, Haynes MP, Bender JR 2003 Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812
49. Pedram A, Razandi M, Sainson RCA, Kim JK, Hughes CC, Levin ER 2007 A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282:22278-22288
50. Benten WP, Stephan C, Lieberherr M, Wunderlich F 2001 Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669-1677
51. Bjornstrom L, Sjoberg M 2005 Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842
52. Abraham IM, Todman MG, Korach KS, Herbison AE 2004 Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 145:3055-3061
53. Watters JJ, Chun TY, Kim YN, Bertics PJ, Gorski J 2000 Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol Endocrinol 14:1872-1881
54. Vasudevan N, Pfaff DW 2007 Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev 28:1-19
55. Acconcia F, Kumar R 2005 Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 238:1-14
56. Michalides R, Griekspoor A, Balkenende A Verwoerd D, Janssen L, Jalink K, Floore A, Velds A, van't Veer L, Neefjes J 2004 Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer. Cancer Cell 5:597-605
57. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
58. Zheng FF, Wu RC, Smith CL, O'Malley BW 2005 Rapid estrogeninduced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol Cell Biol 25:8273-8284
59. Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ 2001 Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem 276:22177-22182
60. Iwase H 2003 Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 10:89-96
61. Pedram A, Razandi M, Aitkenhead M, Hughes CCW, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen: membrane initiated signaling by steroid (MISS) to transcription and cell biology. J Biol Chem 277:50768-50775
62. Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, Webb P, Greene G 2000 Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 230:20-26
63. Duan R, Xie W, Li X, McDougal A, Safe S 2002 Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem Biophys Res Commun 294:384-394
64. Bjornstrom L, Sjoberg M 2002 Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16:2202-2204
65. Krasilnikov MA 2000 Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry 65:59-67
66. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC 2005 Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Res 65:5792-5801
67. Ozaki S, Ikeda S, Ishizaki Y, Kurihara T, Tokumoto N, Iseki M, Arihiro K, Kataoka T, Okajima M, Asahara T 2005 Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep 14:1437-1443
68. Richards JS, Sharma SC, Falender AE, Lo YH 2002 Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol Endocrinol 16:580-599
69. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
70. Cosentino C, Di Domenico M, Porcellini A, Cuozzo C, De Gregorio G, Santillo MR, Agnese S, Di Stasio R, Feliciello A, Migliaccio A, Avvedimento EV 2007 p85 Regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival. Oncogene 26:2095-2103
71. Kim JK, Pedram A, Razandi M, Levin ER 2006 Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 isoforms. J Biol Chem 281:6760-6767
72. Stathopoulos EN, Hatzoglou A, Gravanis A, Castanas E 2004 Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J 18:1594-1596
73. Yue W, Fan P, Wang J, Li Y, Santen RJ 2007 Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells. J Steroid Biochem Mol Biol 106:102-110
74. Fan P, Wang J, Santen RJ, Yue W 2007 Long-term treatment with tamoxifen facilitates translocation of estrogen receptor α out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res 67:1352-1360
75. Razandi M, Pedram A, Rosen E, Levin ER 2004 BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24:5900-5913
76. Datta SR, Brunet A, Greenberg ME 1999 Cellular survival: a play in three Akts. Genes Dev 13:2905-2927
77. Plotkin LI, Ignacio Aguirre J, Kousteni S, Manolagas SC, Bellido T 2005 Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of ERK activation. J Biol Chem 280:7317-7325
78. Yada-Hashimoto N, Nishio Y, Ohmichi M, Hayakawa J, Mabuchi S, Hisamoto K, Nakatsuji Y, Sasaki H, Seino-Noda H, Sakata M, Tasaka K, Murata Y 2006 Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor α. Menopause 3:935-941
79. Acconcia F, Manavathi B, Mascarenhas J, Talukder AH, Mills G, Kumar R 2006 An inherent role of integrin-linked kinase-estrogen receptor α interaction in cell migration. Cancer Res 66:11030-11038
80. Geraldes P, Sirois MG, Tanguay JF 2003 Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 93:399-405
81. Chen JQ, Delannoy M, Cooke C, Yager JD 2004 Mitochondrial localization of ERα and ERβ in human MCF7 cells. Am J Physiol Endocrinol Metab 286:E1011-E1022
82. Yang SH, Liu R, Perez EJ, Wen Y, Stevens Jr SM, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW 2004 Mitochondrial localization of estrogen receptor β. Proc Natl Acad Sci USA 101:4130-4135
83. Pedram A, Razandi M, Wallace D, Levin ER 2006 Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 1749:2125-2137
84. Chen JQ, Yager JD 2004 Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis. Ann NY Acad Sci 1028:258-272
85. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
86. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC 2007 Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 27:1516-1530
87. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
88. Windahl SH, Galien R, Chiusaroli R, Clement-Lacroix P, Morvan F, Lepescheux L, Nique F, Horne WC, Resche-Rigon M, Baron R 2006 Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor. J Clin Invest 116:2500-2509
89. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ 2005 Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146:728-735
90. Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ 2003 A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915-923
91. Chen JR, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, Bellido T, Manolagas SC 2005 Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem 280:4632-4638
92. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, Elias RV, Knapp RR, Zhou X, Cao W 2004 Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 β-estradiol-mediated neuroprotection. J Biol Chem 279:13086-13094
93. Wilson ME, Liu Y, Wise PM 2002 Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Brain Res Mol Brain Res 102:48-54
94. Jung ME, Watson DG, Wen Y, Simpkins JW 2003 Role of protein kinase C in estrogen protection against apoptotic cerebellar cell death in ethanol-withdrawn rats. Alcohol 31:39-48
95. Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C 2005 Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes. Neuroscience 132:581-589
96. Kajta M, Domin H, Grynkiewicz G, Lason W 2007 Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3β intracellular signaling pathway. Neuroscience 145:592-604
97. D'Astous M, Mendez P, Morissette M, Garcia-Segura LM, Di Paolo T 2006 Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol Pharmacol 69:1492-1498
98. Milner TA, Ayoola K, Drake CT, Herrick SP, Tabori NE, McEwen BS, Warrier S, Alves SE 2005 Ultrastructural localization of estrogen receptor β immunoreactivity in the rat hippocampal formation. J Comp Neurol 491:81-95
99. Xu Y, Traystman RJ, Hurn PD, Wang MM 2003 Neurite-localized estrogen receptor-α mediates rapid signaling by estrogen. J Neurosci Res 74:1-11
100. Balthazart J, Cornil CA, Taziaux M, Charlier TD, Baillien M, Ball GF 2006 Rapid changes in production and behavioral action of estrogens. Neuroscience 138:783-791
101. Remage-Healey L, Bass AH 2007 Plasticity in brain sexuality is revealed by the rapid actions of steroid hormones. J Neurosci 27:1114-1122
102. Woolley CS 2007 Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 47:657-680
103. Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM 2007 Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72:381-405
104. Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG, Shaul PW 2007 Direct interactions with Gαi and Gβγ mediate nongenomic signaling by estrogen receptor α. Mol Endocrinol 21:1370-1380
105. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW 1999 Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406
106. Guo X, Razandi M, Pedram A, Kassab G, Levin ER 2005 Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors α and β. J Biol Chem 280:19704-19710
107. de Jager T, Pelzer T, Muller-Botz S, Imam A, Muck J, Neyses L 2001 Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. J Biol Chem 276:27873-27880
108. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
109. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME, Karas RH 2004 17β-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95:692-699
110. Boonyaratanakornkit V, Edwards DP 2004 Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem 40:105-120
111. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280
112. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP 2007 The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21:359-375
113. Faivre EJ, Lange CA 2007 Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27:466-480
114. Skildum A, Faivre E, Lange CA 2005 Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19:327-339
115. Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, Boonyaratanakornkit V, Charreau EH, Bal de Kier Joffe E, Schillaci R, Elizalde PV 2007 Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol 21:1335-1358
116. Daniel AR, Qiu M, Faivre EJ, Ostrander JH, Skildum A, Lange CA 2007 Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:188-201
117. Qiu M, Lange CA 2003 MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. J Steroid Biochem Mol Biol 85:147-157
118. Maller JL, Krebs EG 1980 Regulation of oocyte maturation. Curr Top Cell Regul 16:271-311
119. Hammes SR 2003 The further redefining of steroid-mediated signaling. Proc Natl Acad Sci USA 100:2168-2170
120. Hammes SR 2004 Steroids and oocyte maturation - a new look at an old story. Mol Endocrinol 18:769-775
121. Bayaa M, Booth RA, Sheng Y, Liu XJ 2000 The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism. Proc Natl Acad Sci USA 97:12607-12612
122. Tian J, Kim S, Heilig E, Ruderman JV 2000 Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc Natl Acad Sci USA 97:14358-14363
123. Martinez S, Pasten P, Suarez K, Garcia A, Nualart F, Montecino M, Hinrichs MV, Olate J 2007 Classical Xenopus laevis progesterone receptor associates to the plasma membrane through its ligandbinding domain. J Cell Physiol 211:560-567
124. Martinez S, Grandy R, Pasten P, Montecinos H, Montecino M, Olate J, Hinrichs MV 2006 Plasma membrane destination of the classical Xenopus laevis progesterone receptor accelerates progesterone-induced oocyte maturation. J Cell Biochem 99:853-859
125. Zhu Y, Bond J, Thomas P 2003 Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100:2237-2242
126. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P 2003 Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100:2231-2236
127. Josefsberg Ben-Yehoshua L, Lewellyn AL, Thomas P, Maller JL 2007 The role of Xenopus membrane progesterone receptor β in mediating the effect of progesterone on oocyte maturation. Mol Endocrinol 21:664-673
128. Lutz LB, Kim B, Jahani D, Hammes SR 2000Gprotein β γ subunits inhibit nongenomic progesterone-induced signaling and maturation in Xenopus laevis oocytes. Evidence for a release of inhibition mechanism for cell cycle progression. J Biol Chem 275:41512-41520
129. Sadler SE, Maller JL, Cooper DM 1984 Progesterone inhibition of Xenopus oocyte adenylate cyclase is not mediated via the Bordetella pertussis toxin substrate. Mol Pharmacol 26:526-531
130. Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, Thomas P 2006 Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 20:1519-1534
131. Ashley RL, Clay CM, Farmerie TA, Niswender GD, Nett TM 2006 Cloning and characterization of an ovine intracellular seven transmembrane receptor for progesterone that mediates calcium mobilization. Endocrinology 147:4151-4159
132. Krietsch T, Fernandes MS, Kero J, Losel R, Heyens M, Lam EW, Huhtaniemi I, Brosens JJ, Gellersen B 2006 Human homologs of the putative G protein-coupled membrane progestin receptors (mPRα, β, and γ) localize to the endoplasmic reticulum and are not activated by progesterone. Mol Endocrinol 20:3146-3164
133. Baldi E, Casano R, Falsetti C, Krausz C, Maggi M, Forti G 1991 Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J Androl 12:323-330
134. Baldi E, Luconi M, Bonaccorsi L, Forti G 1998 Nongenomic effects of progesterone on spermatozoa: mechanisms of signal transduction and clinical implications. Front Biosci 3:D1051-D1059
135. Losel R, Breiter S, Seyfert M, Wehling M, Falkenstein E 2005 Classic and non-classic progesterone receptors are both expressed in human spermatozoa. Horm Metab Res 37:10-14
136. Engmann L, Losel R, Wehling M, Peluso JJ 2006 Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. J Clin Endocrinol Metab 91:4962-4968
137. Debose-Boyd RA 2007 A helping hand for cytochrome p450 enzymes. Cell Metab 5:81-83
138. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ 2007 Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5:143-149
139. Thibier-Fouchet C, Mulner O, Ozon R 1976 Progesterone biosynthesis and metabolism by ovarian follicles and isolated oocytes Xenopus laevis. Biol Reprod 14:317-326
140. Lutz LB, Cole LM, Gupta MK, Kwist KW, Auchus RJ, Hammes SR 2001 Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci USA 98:13728-13733
141. Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR 2003 Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 17:1106-1116
142. Yang WH, Lutz LB, Hammes SR 2003 Xenopus laevis ovarian CYP17 is a highly potent enzyme expressed exclusively in oocytes. Evidence that oocytes play a critical role in Xenopus ovarian androgen production. J Biol Chem 278:9552-9559
143. el-Zein G, Boujard D, Garnier DH, Joly J 1988 The dynamics of the steroidogenic response of perifused Xenopus ovarian explants to gonadotropins. Gen Comp Endocrinol 71:132-140
144. Fortune JE 1983 Steroid production by Xenopus ovarian follicles at different developmental stages. Dev Biol 99:502-509
145. White SN, Jamnongjit M, Gill A, Lutz LB, Hammes SR 2005 Specific modulation of nongenomic androgen signaling in the ovary. Steroids 70:352-360
146. Evaul K, Jamnongjit M, Bhagavath B, Hammes SR 2007 Testosterone and progesterone rapidly attenuate plasma membrane Gβγ-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. Mol Endocrinol 21:186-196
147. Gallo CJ, Hand AR, Jones TL, Jaffe LA 1995 Stimulation of Xenopus oocyte maturation by inhibition of the G-protein α S subunit, a component of the plasma membrane and yolk platelet membranes. J Cell Biol 130:275-284
148. Sheng Y, Montplaisir V, Liu XJ 2005 Co-operation of Gsα and Gβγ in maintaining G2 arrest in Xenopus oocytes. J Cell Physiol 202: 32-40
149. Sheng Y, Tiberi M, Booth RA, Ma C, Liu XJ 2001 Regulation of Xenopus oocyte meiosis arrest by G protein βγ subunits. Curr Biol 11:405-416
150. Haas D, White SN, Lutz LB, Rasar M, Hammes SR 2005 The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Mol Endocrinol 19:2035-2046
151. Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, De Falco A, Nanayakkara M, Bottero D, De Stasio R, Varricchio L, Auricchio F 2006 Crosstalk between EGFR and extranuclear steroid receptors. Ann NY Acad Sci 1089:194-200
152. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F 2000 Steroid-induced androgen receptoroestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417
153. Migliaccio A, Varricchio L, De Falco A, Castoria G, Arra C, Yamaguchi H, Ciociola A, Lombardi M, Di Stasio R, Barbieri A, Baldi A, Barone MV, Appella
154. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M 2004 Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64:7156-7168
155. Freeman MR, Cinar B, Kim J, Mukhopadhyay NK, Di Vizio D, Adam RM, Solomon KR 2007 Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes. Steroids 72:210-217
156. Freeman MR, Cinar B, Lu ML 2005 Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends Endocrinol Metab 16:273-279
157. Walker WH 2003 Molecular mechanisms controlling Sertoli cell proliferation and differentiation. Endocrinology 144:3719-3721
158. Cheng J, Watkins SC, Walker WH 2007 Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in Sertoli cells. Endocrinology 148:2066-2074
159. Walker WH 2003 Nongenomic actions of androgen in Sertoli cells. Curr Top Dev Biol 56:25-53
160. Keller-Wood ME, Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24
161. Hinz B, Hirschelmann R 2000 Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm Res 17:1273-1277
162. Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC 2003 Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 144:1164-1174
163. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M 2005 Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 102:19204-19207
164. Limbourg FP, Liao JK 2003 Nontranscriptional actions of the glucocorticoid receptor. J Mol Med 81:168-174
165. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK 2002 Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473-479
166. Lowenberg M, Verhaar AP, Bilderbeek J, Marle J, Buttgereit F, Peppelenbosc MP, van Deventer SJ, Hommes DW 2006 Glucocorticoids cause rapid dissociation of a T-cell-receptor associated protein complex containing LCK and FYN. EMBO Rep 7:1023-1029
167. Schmidt BM, Horisberger K, Feuring M, Schultz A, Wehling M 2005 Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism. Exp Clin Endocrinol Diabetes 113:252-256
168. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW 1995 Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ Res 76:973-979
169. Wehling M, Ulsenheimer A, Schneider M, Neylon C, Christ M 1994 Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging. Biochem Biophys Res Commun 204:475-481
170. Grossmann C, Benesic A, Krug AW, Freudinger R, Mildenberger S, Gassner B, Gekle M 2005 Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol Endocrinol 19:1697-1710
171. Mihailidou AS, Funder JW 2005 Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system. Steroids 70:347-351
172. Mihailidou AS, Mardini M, Funder JW 2004 Rapid, nongenomic effects of aldosterone in the heart mediated by ε protein kinase C. Endocrinology 145:773-780
173. Funder JW 2006 Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology 147:5564-5567
174. Gekle M, Silbernagl S, Oberleithner H 1997 The mineralocorticoid aldosterone activates a proton conductance in cultured kidney cells. Am J Physiol 273:C1673-C1678
175. Gekle M, Freudinger R, Mildenberger S, Silbernagl S 2002 Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells. Am J Physiol Renal Physiol 282:F669-F679
176. Watts 3rd BA, George T, Good DW 2006 Aldosterone inhibits apical NHE3 and HCO3 absorption via a nongenomic ERK-dependent pathway in medullary thick ascending limb. Am J Physiol Renal Physiol 291:F1005-F1013
177. Dudley Jr SC, Baumgarten CM 1993 Bursting of cardiac sodium channels after acute exposure to 3,5,3′-triiodo-L-thyronine. Circ Res 73:301-313
178. Davis FB, Kite Jr JH, Davis PJ, Blas SD 1982 Thyroid hormone stimulation in vitro of red blood cell Ca2+-ATPase activity: interspecies variation. Endocrinology 110:297-298
179. Lawrence WD, Schoenl M, Davis PJ 1989 Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. J Biol Chem 264:4766-4768
180. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ 2005 Inegrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-2871
181. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB 2000 Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032-38039
182. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H 2004 Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19:102-112
183. Mousa SA, Davis FB, Mohamed S, Davis PJ, Feng X 2006 Proangiogenesis action of thyroid hormone and analogs in a threedimensional in vitro microvascular endothelial sprouting model. Int Angiol 25:407-413
184. Lin HY, Tang HY, Shih A, Keating T, Cao G, Davis PJ, Davis FB 2007 Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 72:180-187
185. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin HY 2006 Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66:7270-7275
186. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Stachelek SJ, Leonard JL 2005 Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3′,5′-triiodothyronine. Brain Res Dev Brain Res 154:121-135
187. Davis PJ, Davis FB 1993 Acute cellular actions of thyroid hormone and myocardial function. Ann Thorac Surg 56:S16-S23
188. Davis PJ, Davis FB, Cody V 2005 Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 16:429-435
189. Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ 2004 Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272
190. Zhao X, Lorenc H, Stephenson H, Wang YJ, Witherspoon D, Katzenellenbogen B, Pfaff D, Vasudevan N 2005 Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells. Proc Natl Acad Sci USA 102:4890-4895
191. Furuya F, Hanover JA, Cheng S-Y 2006 Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor. Proc Nat Acad Sci USA 103:1780-1785
192. Eng C 2003 PTEN: one gene, many syndromes. Hum Mutat 22:183-198
193. Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M 2001 Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 61:6105-6111
194. Hiroi Y, Kim H-H, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen N-H, Scanlan TS, Moskowitz MA, Cheng S-Y, Liao JK 2006 Rapid nongenomic actions of thyroid hormone. Proc Nat Acad Sci USA 103:14104-14109
195. Haussler MR, Norman AW 1969 Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 62:155-162
196. Norman AW 2006 Vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147:5542-5548
197. 3 in vivo and in vitro. Mol Endocrinol 18:2660-2671
198. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Moller G, Adamski J, Balling R 2002 Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16:1524-1537
199. 3 require the VDR and influence 24-hydroxylate activity: studies in human skin fibroblasts bearing vitamin D receptor mutations. J Biol Chem 279:7591-7597
200. Buitrago C, Gonzalez PV, de Boland AR 2002 Nongenomic action of 1 α,25(OH)(2)-vitamin D3. Activation of muscle cell PLC γ through the tyrosine kinase c-Src and Ptdlns 3-kinase. Eur J Biochem 269:2506-2515
201. Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW, Manolagas SC 2005 Nongenotropic, anti-apoptotic signaling of 1α,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem 280:14130-14137
202. Rebsamen MC, Sun J, Norman AW, Liao JK 2002 1α,25- Dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91:17-24
203. Berry DM, Clark CS, Meckling-Gill KA 2002 1α,25- Dihydroxyvitamin D3 stimulates phosphorylation of IκBα and synergizes with TPA to induce nuclear translocation of NFκB during monocyte differentiation of NB4 leukemia cells. Exp Cell Res 272:176-184
204. 3-MARRS) and phosphate uptake in intestinal cells. Proc Natl Acad Sci USA 101:7392-7397
205. Rohe B, Safford SE, Nemere I, Farach-Carson MC 2007 Regulation of expression of 1,25D3-MARRS/ERp57/PDIA3 in rat IEC-6 cells by TGFβ and 1,25(OH)2D3. Steroids 72:144-150
206. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE 1999 Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458
207. Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS 2006 Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 20:491-502
208. Kim SH, Katzenellenbogen JA 2006 Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptors. Angew Chem Int Ed Engl 45:7243-7248
209. Marquez DC, Pietras RJ 2001 Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20:5420-5430
210. Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E 2006 Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 5:1342-1351
211. Nemere I, Pietras RJ, Blackmore PF 2003 Membrane receptors for steroid hormones: signal transduction and physiological significance. J Cell Biochem 88:438-445